Equities

Next Science Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert

Next Science Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (AUD)0.145
  • Today's Change0.00 / 0.00%
  • Shares traded4.33m
  • 1 Year change+16.00%
  • Beta2.0786
Data delayed at least 20 minutes, as of Dec 31 2025 02:45 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Next Science Limited is an Australia-based medical technology company. The Company focuses on enhancing patient outcomes, empowering physicians, and driving healthcare innovation through education, research, and cutting-edge product development. Its Durable Medical Equipment (DME) Wound Care includes advanced wound care solutions delivered through partnerships with DME providers, particularly in the United States home health and outpatient settings.

  • Revenue in AUD (TTM)31.54m
  • Net income in AUD-13.48m
  • Incorporated2017
  • Employees--
  • Location
    Next Science LtdTower BThe Zenith L 19, 821 Pacific HighwayChatswood 2000AustraliaAUS
  • Phone+61 28607-5124
  • Websitehttps://www.nextscience.com
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Immuron Ltd7.29m-5.22m10.45m7.00--0.9278--1.43-0.0226-0.02260.03160.03450.56751.504.401,041,000.00-40.62-27.84-49.64-30.6065.3970.18-71.58-182.344.19--0.00--48.6323.6724.81------
Tissue Repair Ltd3.02m-4.24m12.40m----0.891--4.11-0.0701-0.07010.04990.23010.1777--60.84---24.96-24.25-26.50-25.27-----140.49-518.5422.40--0.00--236.85---2.43------
Epsilon Healthcare Ltd6.13m-6.12m12.51m--------2.04-0.0164-0.01640.0167-0.00970.462--4.95---46.14-33.37-156.14-46.4652.2349.34-99.85-136.160.3775-3.921.67---15.813.16-403.56---32.83--
Calmer Co International Ltd8.03m-3.99m13.76m----7.12--1.71-0.0015-0.00150.00290.00061.603.2914.33---79.73-109.82-171.17-197.5042.4941.18-49.69-128.711.22-11.320.5482--88.4859.99-7.13--27.67--
Oncosil Medical Ltd1.26m-15.10m15.73m2.00--3.30--12.47-1.38-1.380.11550.21820.182--2.18---217.79-97.54-382.54-117.83-78.62-54.05-1,196.80-1,258.41---146.890.022--116.34-15.15-26.74---6.31--
Firebrick Pharma Ltd293.42k-2.63m16.10m----9.23--54.87-0.0126-0.01260.00140.00690.13860.86960.4855---124.44-98.41-143.50-109.2835.72---897.84-5,384.554.75--0.00--1,920.80---124.04------
TrivarX Ltd1.13m-943.23k21.92m4.00--0.9308--19.35-0.0018-0.00180.00230.02040.0923-------7.68-33.47-8.32-37.46-----83.27-373.85---27.050.0132--26.383.8934.25--6.29--
Avecho Biotechnology Ltd1.38m-3.62m36.73m29.00--38.46--26.61-0.0011-0.00110.00040.00030.21154.461.91---55.49-61.23-72.92-73.2762.2755.45-262.41-382.044.53-8.030.0647--139.19-23.209.15------
Vitura Health Ltd124.04m3.28m37.78m119.0010.560.78317.120.30460.00540.00540.20340.07281.6916.4310.46--4.1112.755.7217.6227.2130.972.436.061.059.500.2009--0.1341298.23-5.35--129.38--
Little Green Pharma Ltd38.49m5.86m38.21m--6.460.44423.940.99250.01940.01940.12680.28140.42620.819914.01--6.48--7.09--67.46--15.21--0.8728-4.710.0541--43.67--140.77------
Next Science Ltd31.54m-13.48m42.43m--------1.35-0.0462-0.04620.108-0.00272.075.425.69---88.62-72.67-148.75-86.8782.4877.69-42.74-87.991.25-13.181.12--2.8741.2334.94---18.19--
Inoviq Ltd959.32k-6.93m47.16m85.00--2.24--49.16-0.0623-0.06230.00860.14970.04783.730.6725---34.52-43.01-37.36-45.8787.4589.08-722.62-1,543.445.72--0.022--21.1757.69-5.77------
Medical Developments International Ltd39.06m94.00k51.82m68.00547.620.940515.721.330.00080.00080.34690.48910.62211.065.31--0.1497-16.680.1738-18.9275.3572.700.2407-47.083.33--0.0349--17.8211.30100.23-24.33-34.91--
Data as of Dec 31 2025. Currency figures normalised to Next Science Ltd's reporting currency: Australian Dollar AUD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.